Аннотация
Обследованы 50 больных для оценки системной воспалительной реакции в ответ на хирургическое лечение врожденных пороков сердца. Показана зависимость интенсивности и скорости развития воспалительного ответа, степени нарушения баланса между воспалительными медиаторами и их ингибиторами от длительности ИК. Выявлена зависимость между интенсивностью воспалительного ответа и клиническим течением раннего послеоперационного периода, особенности которого могут быть отражением тканевых повреждений воспалительными медиаторами, высвобождающимися после операции с ИК
Литература
1. Ребенок А. Ж., Тихонов И. И., Чиж А. С. Значение интерлейкина-8 и дефензинов в патогенезе хронического гломерулонефрита и пиелонефрита // Тер. архив. - 1999. - № 8. - С. 62-67.
2. Andersen L. W., Landow L., Baen L. et al. Association between gastric intramucosal ph and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-
3. Baldwin A. S. Jr. The NF-kappa B and I Kappa B proteins: new discoveries and insights // Ann. Rev. Immunol. - 1996. - Vol. 14. - P. 649-683.
4. Ben-Abraham R., Weinbroum A. A., Dekel B., Paret G. Chemokines and the inflammatory response following cardiopulmonary bypass - a new target for therapeutic intervention? - a review // Paediatr. Anaesth. - 2003. - Vol. 13. - P. 655-661.
5. Boehringer N., Hagens G., Songeon F. еt al. // Eur. Cytokine Network. - 1999. - Vol. 10, № 2. - P. 211-217.
6. Brown Z., Robson R.L., Westwick J.T. // J. Leukocyte Biol. - 1996. - Vol. 59. - P. 75-80.
7. Butler J., Pathi V. L., Paton R. D. et al. Acutephase responses to cardiopulmonary bypass in children weighing less than 10 kilograms // Ann. Thorac. Surg. - 1996. - Vol. 62. - P. 538-542.
8. Bulter J., Rocker G. M., Westaby S. Inflammatory response to cardiopulmonary bypass // Ibid. - 1993. - Vol. 55. - P. 552-559.
9. Cain B. S., Meldrum D. R., Dinarello C. A. et al. Tumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial function // Crit. Care Med. - 1999. - Vol. 27. - P. 1309-1318.
10. Christman J. W., Lancaster L. H., Blackwell T. S. Nuclear factor kB: a pivotal role in the systemic inflammatory response syndrome and new target for therap. // Intens. Care Med. - 1998. - Vol. 24. - P. 1131-1138.
11. Cochrane C. G., Spragg R. G., Revar S. D. et al. // Amer. Rev. Res. Dis. - 1983. - Vol. 127. - P. 25-27.
12. Dekel B., Markus H., Herzel B. H. et al. In vivo modulation of the allogenic immune response by human fetal kidneys: the role of cytokines, chemokines, and cytolitic effector molecules // Transplantation. - 2000. - Vol. 15. - P. 1470-1478.
13. De Werra I., Jaccard C., Carradin S. B. et al. // Crit. Care Med. - 1997. - Vol. 25. - P. 607-613.
14. Donnelly R. P., Freeman S. L., Hayes M. P. Inhibition of IL-10 expression IFN-gamma upregulates transcription of TNF-alpha in human monocytes // J. Immunol. - 1995. - Vol. 155. - P. 1420-1427.
15. Finkle M. S., Oddis C. V., Jacob T. D. et al. Negative inotropic effects of cytokine on the heart mediated by nitric oxide // Sceince. - 1992. - Vol. 257. - P. 387-389.
16. Finn A., Naik S., Klein N. et al. Interleukin-8 release and neutrophil degranulation after paediatric cardiopulmonary bypass // J. Thorac. Cardiovasc. Surg. - 1993. - Vol. 105. - P. 234-241.
17. Franke A., Lante W., Fackeldey V. et al. Proinflammatory and antiflammatory cytokines after cardiac operation: different cellular sources at different times // Ann. Thorac. Surg. - 2002. - Vol. 74. - P. 363-371.
18. Froon A. H. M., Bemlmans M. H. A., Greve J. W. et al. // Crit. Care Med. - 1994. - Vol. 22. - P. 803-809.
19. Hennein H. A., Ebba H., Rodriguerz J. L. et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization // J. Thorac. Cardiovasc. Surg. - 1994. - Vol. 108. - P. 626-635.
20. Hoch R. C., Schraufstatter I. U., Cochrane C. G. In vivi, in vitro, and molecular aspects of interleukin- 8 receptors // J. Lab. Clin. Med. - 1996. - Vol. 128. - P. 134-145.
21. Idell S., Kucich U., Fein A. et al. // Amer. Rev. Resp. Dis. - 1985. - Vol. 132. - P. 1098-1105.
22. Jonson K., Choi Y., DeGroot E. et al. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation // J. Immunol. - 1998. - Vol. 160. - P. 5130-5135.
23. Jordan J. E., Zhao Z. Q., Vinten-Johansen J. The role of neutrophils in myocardial ischemiareperfusion injury // Cardiovasc. Res. - 1999. - Vol. 43. - P. 860-878.
24. Kaplanski G., Fabrigoule M., Rousou J. A. et al. Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alpha-independent IL-8 secrecion and E-selectin expression // J. Immunol. - 1997.- Vol. 158. - P. 5435-5441.
25. Kawamura T., Wakusawa R., Okada K. et al. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury // Can. J. Anaesth. - 1993. - Vol. 40. - P. 1016-1021.
26. MacMurray J., Abdullah I., Dargie H. et al. Increased concentration of tumour necrosis factor in cachectic patients with chronic heart failure // Brit. Heart J. - 1991. - Vol. 66. - P. 356-358.
27. Meldrum D. R. Tumour necrosis factor in the heart // Amer. J. Physiol. - 1998. - Vol. 274. - P. 577-595.
28. Meldrum D. R., Donnahoo K. K. Role of TNF in mediating renal insuffiency following cardiac surgery: evidence of a postbypass cardiorenal syndrome // J. Surg. Res. - 1999. - Vol. 85. - P. 185-199.
29. Merrit T. A., Cochrane C. R., Holcomb K. et al. // J. Clin. Invest. - 1983. - Vol. 72. - P. 656-666.
30. Metinko A. P., Kunkel S. L., Standiford T. J. et al. Anoxia-hyperoxia induces monocyte-derived interleukin- 8 // Ibid. - 1992. - Vol. 90. - P. 791-798.
31. Nicolson A. C., Nachman R. L., Altieri D. C. et al. Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa // J. Biol. Chem. - 1996. - Vol. 271. - P. 28 407-28 413.
32. Ohri S. K. Systemic inflammatory response and the splanchnic bed in cardiopulmonary bypass // Perfusion. - 1996. - Vol. 11. - P. 200-212.
33. Parsson H. N., Nassberger L., Norgren L. // Int. Angiol. - 1997. - Vol. 16, № 1. - P. 55-64.
34. Raddington D. W., Venkatesh B., Gerstmann D. et al. Intestinal permeability, gastric intramucosal ph, and systemic endotoxemia in patients undergoing cardiopulmonary bypass // J. Amer. Med. Assoc. - 1996. - Vol. 275. - P. 1007-1012.
35. Rothenburger M., Soeparwata R., Deng M. C. et al. The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery // J. Amer. Coll. Cardiol. - 2001. - Vol. 38. - P. 124-130.
36. Schmartz D., Tabardel Y., Preiser J. et al. Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients? // J. Thorac. Cardiovasc. Surg. - 2003. - Vol. 125. - P. 184-190.
37. Shottelius A., Mayo M. W., Sartor R. B., Baldmin A. S. Jr. Interleukin-10 signaling blocks inhibitor of kB kinase activity and nuclear factor kB DNA binding // J. Biol. Chem. - 1999. - Vol. 274. - P. 31 868-31 874.
38. Squadrito F., Altavilla D., Zingarelli B. et al. Tumour necrosis factor involvement in myocardial ischemia-reperfusion injury // Eur. J. Pharmacol. - 1993. - Vol. 237. - P. 223-230.
39. Van Wetering, Mannese-Laztroms S. P., Van Sterkenburg M. A. et al. // Amer. J. Physiol. - 1997. - Vol. 272, № 5 (Pt1). - P. L888-L896.
40. Willems J., Jonian M., Cingue S. et al. // Immunology. - 1989. - Vol. 67. - P. 540-542.
